These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4397094)

  • 1. Failure of propranolol to antagonize halothane depression of the uterus.
    Zauder HL; Pauerstein CJ; Fremming BD; Filner B
    Anesth Analg; 1970; 49(6):948-56. PubMed ID: 4397094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of adrenergic beta receptors by N,N'-bis-[3-(2'ethoxyphenoxy)-2-hydroxypropyl]-ethylenediamine (Falirytmin) as compared to propranolol].
    Mentz P; Bayer BL; Wartner U; Terhaag B; Förster W
    Pharmazie; 1976; 31(9):640-2. PubMed ID: 14343
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between halothane and propranolol on oxytocin-induced uterine contractions.
    Anderson WG; Miller JW
    J Pharmacol Exp Ther; 1975 Feb; 192(2):408-14. PubMed ID: 1117426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atropine, isoproterenol and propranolol on the rabbit bladder contraction induced by intra-arterial administration of acetylcholine and ATP.
    Liu SP; Horan P; Levin RM
    J Urol; 1998 Nov; 160(5):1863-6. PubMed ID: 9783975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique beta adrenergic stimulation and blockade by quinterenol.
    Iorio LC; Moore PF
    J Pharmacol Exp Ther; 1971 Sep; 178(3):509-16. PubMed ID: 4398378
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vivo effects of beta adrenergic stimulation and blockade on the human uterus at term.
    Mahon WA; Reid DW; Day RA
    J Pharmacol Exp Ther; 1967 Apr; 156(1):178-85. PubMed ID: 6023594
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 8. A quantitative study of the effects of isoproterenol and beta-adrenergic blocking agents in the rat uterus in situ.
    Ban T
    Arzneimittelforschung; 1974 Feb; 24(2):179-81. PubMed ID: 4150915
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of adrenergic beta-receptor blockade and mescaline-induced bradycardia.
    Morton JJ; Malone MH
    J Pharm Sci; 1969 Sep; 58(9):1169-70. PubMed ID: 4390569
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
    Levy B
    J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR; Gupta RS; Jain BK
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of fibrinogen degradation products upon the -and -receptors of the adrenergic system in the rat uterus.
    Malofiejew M
    Pol Med J; 1971; 10(3):795-9. PubMed ID: 4399386
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of beta-receptors' blockade upon the action of rat's uterus contractility inhibiting agents.
    Urban J; Zasztowt O
    Pol Med J; 1969; 8(3):753-9. PubMed ID: 5807582
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective beta adrenergic receptor blockade in the rat.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1972 Aug; 182(2):256-63. PubMed ID: 4403093
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenergic reactions of sheep rumen in vitro.
    Kania BF
    Acta Physiol Pol; 1980; 31(4):341-8. PubMed ID: 6255747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review of literature and experimental contribution on KO 592 a drug with beta-adrenolytic activity. II].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(2):117-63. PubMed ID: 4403714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.